BA
The Boeing Company
BA's fundamentals are strong: its operating margin went from −10% to 10% and revenue grew 18%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
EMBJ
Embraer S.A.
There isn't enough reported data to score EMBJ yet.
BA Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Under pressure |
BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.
EMBJ Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| Unavailable | |
| Strong |
EMBJ's profitability and balance sheet are currently healthy. There isn't enough data to rate its revenue and cash flow.
BA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $172 | — |
| Cheap | 51x | $496 | +189% |
| Fair | 82x | $790 | +360% |
| Expensive | 91x | $876 | +411% |
Historical ranges are pointers, not guarantees.
BA has the edge over EMBJ in the historical PE scenario, which offers more potential upside but is not a forecast.
EMBJ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 29x | $14.00 | -82% |
| Fair | 33x | $16.04 | -80% |
| Expensive | 41x | $19.86 | -75% |
| Current | 166x | $79.48 | — |
Historical ranges are pointers, not guarantees.
EMBJ's PE is 166x, but its earnings don't support one, so it isn't a reliable read right now.
BA Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect BA to return to profit, with revenue growing. However, they disagree widely on these estimates.
EMBJ Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Decline | |
| Growth | |
| -- | |
| Limited | |
| -- |
Analysts expect EMBJ's revenue to grow, but its earnings to decline.
BA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $9.66 | +$23.38 |
| Q2 2026 | $2.78 | +$19.33 |
| Q1 2026 | $2.53 | +$20.49 |
| Q4 2025 | $2.48 | +$20.84 |
| Q3 2025 | -$13.72 | -$0.83 |
| Q2 2025 | -$16.55 | -$10.93 |
| Q1 2025 | -$17.96 | -$14.42 |
| Q4 2024 | -$18.36 | -$14.69 |
BA has returned to profit: it earned $9.66 per share over the past year, after losing money the year before.
EMBJ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | $0.48 | 0% |
| Q4 2024 | $0.48 | +118% |
| Q4 2023 | $0.22 | +$0.47 |
| Q4 2022 | -$0.25 | -$0.19 |
| Q4 2021 | -$0.06 | +$0.93 |
| Q4 2020 | -$0.99 | -$0.55 |
| Q4 2019 | -$0.44 | -$0.20 |
| Q4 2018 | -$0.24 | -171% |
EMBJ has the edge over BA in the latest year-over-year earnings comparison.
BA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $24.2B | +3.9% |
| Q2 2026 | $24.6B | +8% |
| Q1 2026 | $22.2B | +14% |
| Q4 2025 | $23.9B | +57% |
| Q3 2025 | $23.3B | +30% |
| Q2 2025 | $22.7B | +35% |
| Q1 2025 | $19.5B | +18% |
| Q4 2024 | $15.2B | -31% |
BA's revenue has grown year over year for seven quarters in a row: $24.2B last quarter, up 3.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.5% | +22 points |
| Q2 2026 | 0.6% | +1.4 points |
| Q1 2026 | 2% | -0.3 points |
| Q4 2025 | 37% | +61 points |
| Q3 2025 | -21% | +12 points |
| Q2 2025 | -0.8% | +5.7 points |
| Q1 2025 | 2.4% | +2.9 points |
| Q4 2024 | -25% | -26 points |
BA's operating margin was 1.5% last quarter, up 22 points from the same quarter a year ago.
EMBJ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $7.6B | +18% |
| Q4 2024 | $6.4B | +21% |
| Q4 2023 | $5.3B | +16% |
| Q4 2022 | $4.5B | +8.2% |
| Q4 2021 | $4.2B | +11% |
| Q4 2020 | $3.8B | +44% |
| Q4 2019 | $2.6B | -48% |
| Q4 2018 | $5.1B | -13% |
EMBJ has the edge over BA in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | 8% | +3.2 points |
| Q4 2024 | 10% | +19 points |
| Q4 2023 | 6% | +12 points |
| Q4 2022 | -2.4% | -3.1 points |
| Q4 2021 | 4.8% | -0.8 points |
| Q4 2020 | -8.6% | -20 points |
| Q4 2019 | -6.2% | -4.3 points |
| Q4 2018 | 0.7% | N/A |
EMBJ's operating margin was 8% last quarter, up 3.2 points from the same quarter a year ago.
BA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $464M | +95% |
| Q2 2026 | $631M | +$831M |
| Q1 2026 | -$1.5B | +$836M |
| Q4 2025 | $375M | +$4.5B |
| Q3 2025 | $238M | +$2.2B |
| Q2 2025 | -$200M | +$4.1B |
| Q1 2025 | -$2.3B | +$1.6B |
| Q4 2024 | -$4.1B | -239% |
BA's free cash flow has turned positive after six years mostly in the red: $16M over the past year.
EMBJ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | $682.8M | +1.8% |
| Q4 2024 | $670.8M | +77% |
| Q4 2023 | $378.3M | -38% |
| Q4 2022 | $615.1M | +49% |
| Q4 2021 | $413.6M | +$1.8B |
| Q4 2020 | -$1.4B | -329% |
| Q4 2019 | $609.3M | -36% |
| Q4 2018 | $953.3M | +83% |
EMBJ generated $2.3B in free cash flow over the past year, about four times what it generated the year before.
BA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +2.1M shares |
| 1 year | +4.3% | +32.8M shares |
| 3 years | +31% | +186M shares |
| 5 years | +35% | +204M shares |
| Available history | +40% | +227M shares |
BA has 793M diluted shares, up 4.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
EMBJ Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -2.2M shares |
| 1 year | -0.5% | -3.4M shares |
EMBJ has the edge over BA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2021 | $2.5M |
| Q4 2017 | $15M |
| Q4 2016 | — |
| Q3 2016 | $742,113 |
BA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 3.0x | Elevated |
| Q2 2026 | 5.7x | High |
| Q1 2026 | 6.0x | High |
| Q4 2025 | 6.9x | High |
| Q2 2024 | 361.8x | High |
| Q1 2024 | 36.1x | High |
| Q4 2023 | 36.4x | High |
| Q3 2023 | 96.1x | High |
BA's net debt is about 3.0 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
EMBJ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2018 | -3.1x | Net Cash |
| Q4 2017 | -1.4x | Net Cash |
EMBJ has more cash than debt.
BA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 31.1 | Neutral |
| Stochastic | 9.6 | Oversold |
BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).
EMBJ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.8 | Neutral |
| Stochastic | 62.6 | Neutral |
EMBJ's weekly RSI is 64 (neutral) and its Stochastic is 63 (neutral).
BA PE vs Industrials Sector
| Metric | BA | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 24x | 26% below |
| PE % | 0 | 58 | 58 pts below |
BA has the edge over EMBJ on valuation relative to its sector.
EMBJ PE vs Industrials Sector
| Metric | EMBJ | Sector median | Relative |
|---|---|---|---|
| PE | 166x | 24x | 589% above |
| PE % | 100 | 58 | 42 pts above |
EMBJ is trading at 166x earnings, a 589% premium to the Industrials sector's median of 24x, though its earnings don't support one.
BA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $184.6 | 7.1% below |
| 20 week MA | $203.8 | 16% below |
| 50 week MA | $215.5 | 20% below |
| 100 week MA | $205.9 | 17% below |
| 200 week MA | $200.6 | 14% below |
BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.
EMBJ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $74.4 | 6.8% above |
| 20 week MA | $72.2 | 10% above |
| 50 week MA | $67.4 | 18% above |
| 100 week MA | $59.2 | 34% above |
| 200 week MA | $40.5 | 96% above |
EMBJ has the edge over BA on trend strength, trading above more of its moving averages.
BA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $330.1 | $217.2 | -34% |
| 2021 | $217.2 | $204.2 | -6% |
| 2022 | $204.2 | $189.1 | -7.4% |
| 2023 | $189.1 | $260.7 | +38% |
| 2024 | $260.7 | $180.7 | -31% |
| 2025 | $180.7 | $216.4 | +20% |
| 2026 YTD | $216.4 | $171.6 | -21% |
BA has finished lower in four of the last six years. It's down 21% so far in 2026.
EMBJ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.4 | $6.52 | -66% |
| 2021 | $6.52 | $17.2 | +163% |
| 2022 | $17.2 | $11.0 | -36% |
| 2023 | $11.0 | $18.5 | +68% |
| 2024 | $18.5 | $36.5 | +98% |
| 2025 | $36.5 | $64.4 | +77% |
| 2026 YTD | $64.4 | $79.5 | +23% |
EMBJ has the edge over BA on returns for 2026, with the stronger performance.